Relapse Prevention with Second Generation Tyrosine Kinase Inhibitors for Ph+ve Acute Leukemia after Allogenic Stem Cell Transplantation.

Faiz K. Anwer,Zabih Warraich,Atif Sohail,Theresa Thai,Azka Latif,Vikas Kapoor,Keri Renee Maher,Faiza Hassan Warraich,Sami Warraich, Zeeshan Baig,Adeela Mushtaq,Pavan Tenneti,Ali McBride

Journal of clinical oncology（2018）

引用 0|浏览21

暂无评分

摘要

7050Background: Relapse after allogeneic hematopoietic stem cell transplantation (AlloHSCT) for Ph+ve acute lymphoblastic leukemia (Ph+ ALL) remains the major cause of treatment failure. Use of tyr...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要